Heather Thomas

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Heather Thomas is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in adjuvant androgen deprivation therapy, adjuvant therapy, and metastasis.

Publications per year

2024–2024

Publications

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab

Ludimila Cavalcante, Sreenivasa R Chandana, Nehal J. Lakhani et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2